Related Experiment Video
Updated: Jun 28, 2025

Three-Dimensional 3D Tumor Spheroid Invasion Assay
Published on: May 1, 2015
Kca3.1-Related Cellular Signalling Involved in Cancer Proliferation
Christian G Calderón Artavia1, Francisco A Arvelo Álvarez2,3
1Laboratorio de Fisiología y Biofísica, Instituto de Biología Experimental (IBE), Facultad de Ciencias, Universidad Central de Venezuela, christian.calderon@ciens.ucv.ve.
Abstract:
Anomalous expression of potassium channels in cancer tissues is associated with several cancer hallmarks that support deregulated proliferation and tumor progression. Ion channels seem to influence cell proliferation; however, the crucial molecular mechanisms involved remain elusive. Some results show how extracellular mitogenic signals modulate ion channel activity through intracellular secondary messengers. It is relevant because we are beginning to understand how potassium channels can affect the proliferative capacity of cells, either in normal mitogen-dependent proliferation or in mitogen-unresponsive proliferation. Calciumdependent potassium channels have been implicated in cell cycle signaling in many cancerous cell lines. In particular, the so-called intermediate conductance KCa3.1 (IKCa) is reported to play a significant role in uncontrolled cell cycle signaling, among other malignant processes driven by cancer hallmarks. In addition to these features, this channel can be subjected to specific pharmacological regulation, making it a promising cornerstone for understanding the signaling behavior of several types of cancer and as a target for chemotherapeutic approaches. This review is dedicated to the connection of KCa3.1 activity, in canonical and non-canonical ways, to the cell cycle signaling, including the cooperation with calcium channels to generate calcium signals and its role as a mediator of proliferative signals.
Insights
Potassium channels, particularly KCa3.1 (intermediate conductance calcium-activated potassium channel), are crucial in cancer cell proliferation and signaling. Targeting KCa3.1 offers a promising avenue for novel cancer chemotherapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Biophysics
Background:
- Anomalous potassium channel expression is linked to cancer hallmarks like proliferation and tumor progression.
- The precise molecular mechanisms by which ion channels influence cancer cell proliferation remain largely unknown.
- Calcium-dependent potassium channels are implicated in cell cycle signaling within numerous cancer cell lines.
Approach:
- This review explores the role of the intermediate conductance calcium-activated potassium channel, KCa3.1 (IKCa), in cancer cell cycle signaling.
- It examines how KCa3.1 activity, through canonical and non-canonical pathways, mediates proliferative signals.
- The review also investigates KCa3.1's interaction with calcium channels in generating calcium signals.
Key Points:
- KCa3.1 channels are significantly involved in uncontrolled cell cycle signaling and other malignant processes.
- Extracellular mitogenic signals can modulate ion channel activity via intracellular secondary messengers.
- KCa3.1 channels are amenable to specific pharmacological regulation, highlighting their therapeutic potential.
Conclusions:
- Understanding KCa3.1's role in cell cycle signaling is vital for deciphering cancer progression.
- KCa3.1 represents a promising target for developing new chemotherapeutic approaches against various cancers.
- Further research into KCa3.1's function can illuminate signaling behaviors in diverse cancer types.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

